Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 11
Submit an article Journal homepage
498
Views
14
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas

Ioanna SakellariHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, GreeceCorrespondence[email protected]
,
Despoina MallouriHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Ioannis BatsisHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Chrysa ApostolouHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Varnavas KonstantinouHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Eleni-Maria AbelaHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Vasiliki DoukaHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Anastasia MarvakiHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Kyriakos KarypidisHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Michalis IskasHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Panayiotis BaliakasHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Panayotis KaloyannidisHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Evangelia YannakiHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Damianos SotiropoulosHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
,
Giorgos KouvatseasHellenic Cooperative Oncology Group (HeCOG), Athens, Greece
,
Christos SmiasHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
&
Achilles AnagnostopoulosHematology Department and BMT Unit, “George Papanicolaou” Hospital, Thessaloniki, Greece
 show all
Pages 3071-3081 | Received 08 Nov 2014, Accepted 04 Mar 2015, Published online: 07 Apr 2015

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Agathe Vély, Marie-Anne Couturier, Pascal Delepine, Ronan Le Calloch, Marjan Ertault, Thomas Gastinne, Chloé Plichon, Anne Lebreton, Marie-Antoinette Lester, Gaelle Larhantec, Nicolas Cormier, Sophie Fouquet, Roch Houot, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Corentin Orvain. (2023) Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma. Leukemia & Lymphoma 0:0, pages 1-10.
Read now

Articles from other publishers (13)

Janel R. Long‐Boyle, Donald B. Kohn, Ami J. Shah, Sueli Marques Spencer, Julian Sevilla, Claire Booth, José Luis López Lorenzo, Eileen Nicoletti, Arpita Shah, Meredith Reatz, Joana Matos & Jonathan D. Schwartz. (2023) Busulfan and subsequent malignancy: An evidence‐based risk assessment. Pediatric Blood & Cancer 71:1.
Crossref
Agathe Vely, Jérôme Paillassa, Christopher Nunes Gomes, Aurélien Giltat, Sophie Fouquet, Anne Lebreton, Marion Klemencie, Aline Clavert, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Corentin Orvain. (2023) Toxicity Profile According to Etoposide and Cytarabine Dosing in Patients with Lymphoma Receiving Autologous Stem Cell Transplantation Following BEAM Conditioning. Annals of Hematology 102:8, pages 2225-2231.
Crossref
Panayotis Kaloyannidis, Rawan Omari, Eman Eldebawy, Eshrak Al Shaibani, John Apostolidis, Taghreed Hindi, Heba Raslan, Ayed Al Garni, Ahmed Al Buali, Khalid Al Anezi & Hani Al Hashmi. (2021) Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience. Clinical Lymphoma Myeloma and Leukemia 21:2, pages e112-e119.
Crossref
Eren GUNDUZ, Hava ÜSKÜDAR TEKE, Cengiz BAL & Tuba BULDUK. (2020) Lenfomada Otolog Kök Hücre Nakli Hazırlama Rejimi Olarak Beam ve Bucye Protokollerinin Karşılaştırılması. OSMANGAZİ JOURNAL OF MEDICINE.
Crossref
Gregorio Jaimovich, Maria Belen Rosales Ostriz, Martin Castro, Leandro Riera, Cecilia Foncuberta, Hector Longoni, Agustina Cia, Patricio Duarte, Adriana Vitriu, Francisco Lastiri & Robert Peter Gale. (2019) CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma. Bone Marrow Transplantation 55:1, pages 265-267.
Crossref
Sara Singer, Nidhi Sharma, Robert Dean, Qiuhong Zhao, Donna Abounader, Patrick Elder, Craig C. Hofmeister, Don M. Benson, Ashley Rosko, Sam Penza, Leslie Andritsos, Sumithira Vasu, Samantha Jaglowski, Basem M. William, Brian Bolwell, Brad Pohlman, Matt Kalaycio, Deepa Jagadeesh, Brian Hill, Ronald Sobecks, Steven M. Devine, Navneet S. Majhail & Yvonne A. Efebera. (2019) BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin’s lymphomas. Bone Marrow Transplantation 54:10, pages 1553-1561.
Crossref
Ioanna Sakellari, Eleni Gavriilaki, Michail Iskas, Zoi Bousiou, Aristotelis Chatziioannidis, I. Batsis, Despina Mallouri, Varnavas Constantinous, Niki Stavroyianni, Antonia Syrigou, Anastasia Marvaki, Maria Pilavaki, Styliani Papaemmanouel & Achilles Anagnostopoulos. (2019) Brentuximab vedotin and anti‐PD1 treatment optimize survival in chemo‐refractory Hodgkin lymphoma patients: Real‐world data. Hematological Oncology 37:4, pages 490-492.
Crossref
Parastoo B. Dahi, Hillard M. Lazarus, Craig S. Sauter & Sergio A. Giralt. (2018) Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma. Bone Marrow Transplantation 54:7, pages 943-960.
Crossref
Maria Gavriilaki, Ioanna Sakellari, Eleni Gavriilaki, Vasilios K. Kimiskidis & Achilles Anagnostopoulos. (2019) Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents. Stem Cells International 2019, pages 1-9.
Crossref
Ioanna Sakellari, Eleni Gavriilaki, Stella Bouziana, Varnavas Constantinou, Despina Mallouri, Anna Vardi, Anastasia Marvaki, Ioannis Batsis, Damianos Sotiropoulos & Achilles Anagnostopoulos. (2018) BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma. Bone Marrow Transplantation 54:6, pages 921-923.
Crossref
Sara Singer, Robert Dean, Qiuhong Zhao, Nidhi Sharma, Donna Abounader, Patrick Elder, Craig C. Hofmeister, Don M. Benson, Ashley Rosko, Sam Penza, Leslie Andritsos, Sumithira Vasu, Samantha Jaglowski, Basem M. William, Brian Bolwell, Brad Pohlman, Matt Kalaycio, Deepa Jagadeesh, Brian Hill, Ronald Sobecks, Steven M. Devine, Navneet S. Majhail & Yvonne A. Efebera. (2019) BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation 25:6, pages 1107-1115.
Crossref
Romeo Gabriel Mihăilă. (2017) Liver Involvement in Hodgkin's Lymphoma: Types of Injuries and Therapeutic Implications. International Journal of Pharmacology, Phytochemistry and Ethnomedicine 8, pages 1-15.
Crossref
G Damaj, J Cornillon, K Bouabdallah, R Gressin, S Vigouroux, T Gastinne, F Ranchon, H Ghésquières, G Salles, I Yakoub-Agha & E Gyan. (2017) Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. Bone Marrow Transplantation 52:7, pages 941-949.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.